GlobalData's clinical trial report, "Shock Global Clinical Trials Review, H2, 2012" provides data on the Shock clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Shock. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Shock. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords
Shock Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Shock, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Table of Contents
TOC
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Shock 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Shock 24
Subjects Recruited Over a Period of Time 26
Prominent Sponsors 27
Top Companies Participating in Shock Therapeutics Clinical Trials 29
Prominent Drug Comparison 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
AstraZeneca PLC 32
Clinical Trial Overview of AstraZeneca PLC 32
Ferring Pharmaceuticals, Inc. 33
Clinical Trial Overview of Ferring Pharmaceuticals, Inc. 33
Sangart, Inc. 34
Clinical Trial Overview of Sangart, Inc. 34
Thrombologic ApS 35
Clinical Trial Overview of Thrombologic ApS 35
Brahms AG 36
Clinical Trial Overview of Brahms AG 36
Herzzentrum Goettingen 37
Clinical Trial Overview of Herzzentrum Goettingen 37
Athlomics Pty Ltd 38
Clinical Trial Overview of Athlomics Pty Ltd 38
ArgiNOx Pharmaceuticals, Inc. 39
Clinical Trial Overview of ArgiNOx Pharmaceuticals, Inc. 39
Laboratoire francais de Fractionnement et de Biotechnologies 40
Clinical Trial Overview of Laboratoire francais de Fractionnement et de Biotechnologies 40
Aventis Behring GmbH 41
Clinical Trial Overview of Aventis Behring GmbH 41
Eli Lilly and Company 42
Clinical Trial Overview of Eli Lilly and Company 42
B. Braun Melsungen AG 43
Clinical Trial Overview of B. Braun Melsungen AG 43
Atox Bio Inc. 44
Clinical Trial Overview of Atox Bio Inc. 44
Innogene Kalbiotech Pte. Ltd. 45
Clinical Trial Overview of Innogene Kalbiotech Pte. Ltd. 45
Eisai Inc. 46
Clinical Trial Overview of Eisai Inc. 46
Green Cross Corporation 47
Clinical Trial Overview of Green Cross Corporation 47
Children's Healthcare of Atlanta Inc. 48
Clinical Trial Overview of Children's Healthcare of Atlanta Inc. 48
Medtronic Cardiac Rhythm Disease Management 49
Clinical Trial Overview of Medtronic Cardiac Rhythm Disease Management 49
NORTHFIELD LABORATORIES INC 50
Clinical Trial Overview of NORTHFIELD LABORATORIES INC 50
Research & Diagnostic Antibodies 51
Clinical Trial Overview of Research & Diagnostic Antibodies 51
Clinical Trial Overview of Top Universities / Institutes / Hospitals 52
Sapienza University of Rome 52
Clinical Trial Overview of Sapienza University of Rome 52
Assistance Publique - Hopitaux de Paris 53
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 53
Beth Israel Deaconess Medical Center 54
Clinical Trial Overview of Beth Israel Deaconess Medical Center 54
Southeast University 55
Clinical Trial Overview of Southeast University 55
National Taiwan University Hospital 56
Clinical Trial Overview of National Taiwan University Hospital 56
Imperial College London 57
Clinical Trial Overview of Imperial College London 57
University of Sao Paulo 58
Clinical Trial Overview of University of Sao Paulo 58
Charite- Universitatsmedizin Berlin 59
Clinical Trial Overview of Charite- Universitatsmedizin Berlin 59
The University of Texas Health Science Center at Houston 60
Clinical Trial Overview of The University of Texas Health Science Center at Houston 60
The Medical Center Leeuwarden 61
Clinical Trial Overview of The Medical Center Leeuwarden 61
University of California, San Francisco 62
Clinical Trial Overview of University of California, San Francisco 62
University Hospital Inselspital, Berne 63
Clinical Trial Overview of University Hospital Inselspital, Berne 63
Austin Health 64
Clinical Trial Overview of Austin Health 64
Carolinas Healthcare System 65
Clinical Trial Overview of Carolinas Healthcare System 65
Medical University of Vienna 66
Clinical Trial Overview of Medical University of Vienna 66
Assaf-Harofeh Medical Center 67
Clinical Trial Overview of Assaf-Harofeh Medical Center 67
Herlev Hospital 68
Clinical Trial Overview of Herlev Hospital 68
The University of Texas Health Science Center at San Antonio 69
Clinical Trial Overview of The University of Texas Health Science Center at San Antonio 69
Seattle Children's Hospital 70
Clinical Trial Overview of Seattle Children's Hospital 70
Innsbruck Medical University 71
Clinical Trial Overview of Innsbruck Medical University 71
Five Key Clinical Profiles 72
Appendix 98
Abbreviations 98
Definitions 98
Research Methodology 99
Secondary Research 99
About GlobalData 100
Contact Us 100
Disclaimer 100
Source 101
List of Tables
List of Tables
Shock Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8
Shock Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Shock Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Shock Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11
Shock Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12
Shock Therapeutics Clinical Trials, North America, Top Countries, 2012* 13
Shock Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 14
Shock Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 15
Shock Global Clinical Trials Review, H2, 2012 published by GlobalData in July 24, 2012. This report consists of Pages: 101 and the price starts from US $ 2500.
The contents of this page may be different from the latest version. Please contact us for details.
